The global DNA Oligonucleotide Synthesis market size is expected to reach USD 19.64 Billion by 2028 and register a CAGR of 17.9%, according to the latest report by Reports and Data. Key factors such as advancements in healthcare and biotechnology sectors, rising government funding, and expansion of manufacturing unit owing to increasing demand for oligonucleotides are driving global market revenue growth.
DNA Oligonucleotide Synthesis is a chemical synthesis process of short nucleic acid fragments, widely used in various laboratory procedures to develop customized oligonucleotides of desired sequence. Synthetic oligonucleotides are also used in clinical settings to detect autoimmune antibodies. Advancements in synthesis techniques, increasing cases of various neurological and infectious diseases, and rising demand for oligonucleotides in various application settings such as research, drug discovery, synthetic biology, and diagnosis is boosting global market growth. Increasing government investments for research projects in genomics and synthetic biology and rising focus on personalized medicine are also fueling global market growth. In addition, increasing investments by market players and high demand for DNA Oligonucleotide Synthesis technologies by private and public firms for ongoing research is further fueling market growth.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/946
This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.
Some key highlights in the report:
- The reagents consumables segment is expected to account for significant revenue growth over the forecast period. High demand for various reagents for each step during synthesis is boosting segment revenue growth.
- Among the application segments, the therapeutic segment is expected to register highest CAGR between 2021 and 2028. High revenue growth is attributable to growing adoption of oligonucleotides as therapeutic drugs to treat various infectious and rare genetic disorders.
- The hospital segment is expected to account for robust revenue growth throughout the forecast period owing to increasing demand for oligonucleotide drugs to treat various infectious, neurological, and rare genetic diseases along with rise in the number of inpatients and outpatient visits.
- North America accounted for largest market share in terms of revenue in 2020 and is expected to continue dominating other regional markets throughout the forecast period. Factors such as high use of oligonucleotides, well-developed healthcare infrastructure, rapid advancements in genomics, diagnostic screening, and high investments in research and development activities are fueling market revenue growth.
- Asia Pacific is expected to register fastest CAGR of 14.8% over the forecast period owing to increasing government funding for research, growing adoption of therapeutics, and rising awareness about various DNA Oligonucleotide Synthesis applications.
Competitive Landscape:
The report also focuses on details of each market player including its global position, financial standing, revenue generation, company overview, and product service portfolio. The DNA Oligonucleotide Synthesis market is extremely competitive and consists of several key players at the regional and global levels. Key players are focused on adopting various strategies such as new product launches, mergers and acquisitions, investments in RD, partnerships, joint ventures, and collaborations to strengthen their market position and enhance their product portfolio.
Leading companies operating in the market are:
- Agilent Technologies, Inc
- ATDBio Ltd.
- Bio-Synthesis, Inc.
- BioAutomation Corporation
- LGC Biosearch Technologies
- Biogen International
- Sarepta Therapeutics
- Eurofins Genomics
- Eurogentec
- GeneDesign, Inc.
- GE Healthcare
- GenScript, Inc.
- Others
Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/946
The report also offers detailed insights about market segmentation based on type, application and regional bifurcation:
DNA Oligonucleotide Synthesis Market Segmentation:
Global DNA Oligonucleotide Synthesis Market: Segmentation By Type (Revenue, USD Million; Volume in Tons, 2018–2028)
- Reagents Consumables
- Equipment
- Synthesized oligonucleotides
- DNA oligonucleotides
- RNA oligonucleotides
- Others\
By Application Type (Revenue, USD Million; Volume in Tons, 2018–2028)
- Research
- Polymerase Chain Reaction
- Next Generation Sequencing
- Others
- Therapeutics
- Antisense Oligonucleotides
- Nucleic Acid Aptamers
- Diagnostics
Regional Outlook:
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
- Latin America (Brazil, Rest of LATAM)
- Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of the Middle East Africa)
Some essential purposes of the DNA Oligonucleotide Synthesis market research report:
- Vital Developments: Custom investigation provides critical improvements to the DNA Oligonucleotide Synthesis market, including RD, new item shipment, coordinated efforts, development rate, partnerships, joint efforts, and local development of rivals working in the market on a global scale and regional.
- Market Characteristics: The report contains DNA Oligonucleotide Synthesis market highlights, income, limit, limit utilization rate, value, net, creation rate, generation, utilization, import, trade, supply, demand, cost, part of the industry in general, CAGR, and gross margin. Likewise, the market report offers an exhaustive investigation of the elements and their most recent patterns, along with Service market fragments and subsections.
- Investigative Tools: This market report incorporates the accurately considered and evaluated information of the major established players and their extension into the DNA Oligonucleotide Synthesis market by methods. Systematic tools and methodologies, for example, Porter’s Five Powers Investigation, Possibilities Study, and numerous other statistical investigation methods have been used to analyze the development of the key players working in the DNA Oligonucleotide Synthesis market.
- Convincingly, the DNA Oligonucleotide Synthesis report will give you an unmistakable perspective on every single market reality without the need to allude to some other research report or source of information. This report will provide all of you with the realities about the past, present, and eventual fate of the DNA Oligonucleotide Synthesis market.
Request customization of the report @ https://www.reportsanddata.com/request-customization-form/946
Thank you for reading the report. Kindly note that we also offer customized reports according to the client's requirements. Contact us to know more about the customization feature and our team will provide you with the best-customized report.
Explore More Industry Research by Reports and Data:
Lewy Body Dementia Treatment Market @ https://www.biospace.com/article/rising-prevalence-of-alzheimer-s-disease-and-related-disorders-is-expected-to-drive-the-growth-of-lewy-body-dementia-treatment-market-till-2030-reports-and-data/
Foot Ulcers Market @ https://www.biospace.com/article/prevalence-of-chronic-wounds-associated-with-diabetes-is-expected-to-drive-growth-foot-ulcers-market-over-the-forecast-period-2022-2030/
Achondroplasia Market @ https://www.biospace.com/article/north-america-can-be-expected-to-register-the-highest-revenue-share-of-achondroplasia-market-during-the-forecast-period-2022-2030-reports-and-data/
Lipodystrophy Market @ https://www.biospace.com/article/north-america-can-be-expected-to-register-rapid-revenue-growth-of-lipodystrophy-market-over-the-forecast-period-2022-2030/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Read the innovative blog at https://www.reportsanddata.com/blogs
Check out our upcoming research report at https://www.reportsanddata.com/upcoming-reports
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update: https://www.youtube.com/channel/UChLqKTFLm6sVBLEUjnadIhQ/videos
